The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
نویسندگان
چکیده
منابع مشابه
The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
BACKGROUND Monoamine oxidase-B (MAO-B) inhibitors are widely used in the treatment of Parkinson's disease. They increase vital monoamine neurotransmitters in the brain. However, there is a need for safer natural reversible MAO inhibitors with MAO-B selectivity. Our previous studies showed that Psoralea corylifolia seeds (PCS) extract contains compounds that inhibit monoamine oxidase-B. METHOD...
متن کاملSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.
Monoamine oxidase B (MAO-B) has been implicated in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative disorders. Increased MAO-B expression in astroglia has been observed adjacent to amyloid plaques in AD patient brains. This phenomenon is hypothesized to lead to increased production of hydrogen peroxide and reactive oxygen species (ROS), thereby contributing to AD patholo...
متن کاملIsolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
It is well established that tobacco smokers have reduced levels of monoamine oxidase activities both in the brain and peripheral organs. Furthermore, extensive evidence suggests that smokers are less prone to develop Parkinson's disease. These facts, plus the observation that inhibition of monoamine oxidase B protects against the parkinsonian inducing effects of the nigrostriatal neurotoxin 1-m...
متن کاملAn evaluation of phospholipids as regulators of monoamine oxidase A and monoamine oxidase B activities.
When rat liver mitochondria are treated with the phospholipase A2 isolated from Naja naja venom in amounts sufficient to cause about 70% loss of mitochondrial phospholipids, both of the monoamine oxidase isozymes monoamine oxidase A and monoamine oxidase B are reduced in activity. With both monoamine oxidases, phospholipase treatment affects the enzyme’s affinity for the amine substrates rather...
متن کاملMapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone.
Befloxatone is a competitive and reversible inhibitor of monoamine oxidase-A (MAOI-A). The aim of the study was to characterize the in vivo properties of [(11)C]befloxatone and to validate its use as a ligand for the study of MAO-A by positron emission tomography (PET). PET studies were performed in baboons after i.v. injection of [(11)C]befloxatone (551 +/- 70 MBq, i.e.14.9 +/- 1.9 mCi). [(11)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Complementary and Alternative Medicine
سال: 2017
ISSN: 1472-6882
DOI: 10.1186/s12906-016-1525-y